Requests similar to 'Availability and funding of WHO Essential Medicines'
Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Awaiting classification.
Good morning Belinda
Please find attached PHARMAC's response to your recent request for information about the funding of Whole Thyroid Extract and Lio...
Trikafta "27 more years at full health" claim.
Response by Pharmaceutical Management Agency to Laydan Mortensen on .
Successful.
Kia ora Laydan
Please find attached a response to your request for official information.
Ngâ mihi,
Government Services | Pharmac
___________________...
Pharmac Budget Bids
Response by Pharmaceutical Management Agency to Jennifer Jiayi on .
Awaiting classification.
Kia ora Jennifer
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
Has Pharmac Ever Funded A Sativex Prescritpion?
Response by Pharmaceutical Management Agency to Gregory Soar on .
Successful.
Dear Mr Soar,
Please find attached letter regarding your OIA request on 26 June 2015.
Kind regards
Alexis Poppelbaum
PHARMAC
24 July 20...
Supply agreement with Pfizer for supply of Cominarty brand of Covid-19 vaccine
Response by Pharmaceutical Management Agency to John Armstrong on .
Partially successful.
Kia ora John
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
____...
Which thyroid medications and bio-identical T4, T3 equivalents meet criteria for government funding
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Successful.
Good morning Ms Hodson,
Please find attached PHARMAC’s response to your OIA request.
Kind regards
Alexis Poppelbaum
PHARMAC
28 August 2...
Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Please find attached a response to your request for information about
remdesivir.
Ngā mihi
Melody Willis ([1]she/h...
Cost of HPV vaccine
Response by Pharmaceutical Management Agency to Virginia Crawford on .
Successful.
Dear Virginia
Please find attached a response to your request.
Kind regards
Donna
Donna Jennings | Communications Advisor
3 August 2017
Via email:...
Information regarding medicinal cannabis prescriptions
Response by Pharmaceutical Management Agency to Mr McDonald on .
Information not held.
Kia ora Mr McDonald,
Please find a response to your request attached to this email.
Kind regards,
Gendi McFadyen| Government Services Advisor
Te Pāt...
Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Please find a response for your request for information attached with this email.
Ngā mihi
Simon
Simon Mitchell | Senior Policy Adviso...
Clarification of Pharmaceutical Schedule from Prior Request
Response by Pharmaceutical Management Agency to Amanda Ashley on .
Successful.
Hi Amanda
1. This Guideline referred to was produced by the NZ Guidelines Group. Please note that this is a guideline for prescribing only, it does not...
Citation list for PHARMAC funded thyroid medications and patient survey data
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Partially successful.
Dear Belinda
Please find attached further correspondence in relation to your request for information about thyroid medications (OIA reference 2019-20-...
Official Information Act Request – Provisions of Pfizer Vaccine Procurement Agreements
Response by Ministry of Business, Innovation & Employment to John Armstrong on .
Refused.
Kia ora John
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
7 - ADHD Medicines, Funding, Access, and Equity
Request sent to Pharmaceutical Management Agency by Elspeth Baker-Vevers on .
Partially successful.
Kia ora,
I’m making this Official Information Act request as part of ADHDInquiryNZ, a grassroots, unfunded, and non-partisan volunteer initiative sup...
Request Regarding the top dispensed drugs/most expensive drugs for 2016
Response by Pharmaceutical Management Agency to Sam Wagener on .
Successful.
Hi Sam
Please find attached a response to your OIA request.
Kind regards
Donna Jennings
PHARMAC
24 February 2016
Via email: [email address]>
Dear Sam...
PrEP Correspondence
Response by Pharmaceutical Management Agency to Gemma Crawley on .
Information not held.
Hi Gemma
Sorry - by timeframe - I meant the time period for the correspondence you want us to include - ie how far back do you want us to search.
If th...
Assessment bias toward new medicines - Ivermectin and Pfizer antiviral PF-07321332
Response by Ministry of Health to Adam Irish on .
Partially successful.
Kia ora Adam
Please find a response to your request attached with this email.
Ngā mihi
Melody Willis ([1]she/her) | Government Se...
The 2022 Therapeutic Products Bill
Response by Andrew Little to Tracy Livingston on .
Awaiting classification.
Kia ora Tracy,
Please find attached a response to your request for information.
Ngā mihi
OIA Services Team
Manatū Hauora | Ministry of Hea...
Management of Stelazine (trifluoperazine) supply
Response by Pharmaceutical Management Agency to WGRH on .
Information not held.
Dear Dr Harrison,
PHARMAC is extending the response date for your request, please see letter attached.
Please let me know if you have any questions o...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Response by Pharmaceutical Management Agency to J Bruning on .
Successful.
Kia ora
Please find a response to your request for information attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Services Adv...
Medicines Regulations changes around increasing the period of supply: conflict between the Regulations and the Pharmac Schedule
Request sent to Health New Zealand by Tiffany Wright on .
Awaiting classification.
The Pharmac Schedule allows for funded dispensings of quantities greater than 90-day or 180-day lots at one time in some pragmatic circumstances suc...
Information regarding Dexcom CGMS and Libre FGMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith
Further to our previous email to you on Friday 19 March 2021, please find
attached the final response to your request for inform...
Dear Gregory
Please find attached PHARMAC’s response to your recent OIA request.
Kind regards,
Lauren Grierson
PHARMAC
8 April...
List of most most costly and most prescribed medications
Response by Pharmaceutical Management Agency to Sam Wagener on .
Refused.
Dear Sam
Thank you for your request below under the Official Information Act, 1982.
The information requested appears to be more closely associated to...
Vanlafaxine - Bioavailability studies
Response by Pharmaceutical Management Agency to R Whyte on .
Awaiting classification.
Dear R Whyte
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
16 April 2018
Via Email: [e...